marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2024
added 12-17-2024
Sonnet BioTherapeutics Holdings Financial Ratios 2011-2024 | SONN
Annual Financial Ratios Sonnet BioTherapeutics Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.2 | -0.0 | -0.0 | - | -1.0 | -0.8 | -1.0 | -1.4 | -1.1 | -0.8 | -462.8 | -872.9 | -630.7 | - |
P/S |
60.5 | 1.4 | 0.5 | - | - | - | 0.2 | 0.2 | 0.2 | 0.3 | 99.3 | 551.9 | 226673.6 | - |
EPS |
-11.3 | -145.1 | -150.5 | -14.2 | -7.0 | -2.6 | -2.0 | -2.7 | -4.2 | -0.9 | -0.9 | -1.2 | -1.2 | -1.0 |
EV (Enterprise Value) |
4.23 M | 3.59 M | 5.51 M | -20.9 M | 22.8 M | 6.29 M | 28.6 M | 29 M | 29.8 M | 29.3 M | 2.98 B | 4.56 B | 734 M | 4.16 M |
EBITDA per Share |
-18.1 | -145 | -150 | -14.3 | -2.57 | -22.9 | -26.2 | -31.4 | -3.33 | -67.5 | -0.389 | -0.783 | -0.71 | - |
EV/EBITDA |
0.8 | -0.7 | -0.8 | -3.7 | -4.4 | -48.5 | -2.6 | -1204.2 | -1332.0 | -870.4 | -1.2 | |||
PEG |
-0.0 | -0.0 | -0.0 | - | -0.01 | -0.02 | -0.04 | -0.04 | -0.02 | 0.0 | -30.17 | 40.17 | 6.83 | - |
P/B |
-2.3 | -0.9 | -0.1 | - | 8.3 | -1.4 | 0.9 | 0.9 | 0.7 | 0.5 | 197.9 | 405.0 | 132.6 | - |
P/CF |
-0.1 | -0.0 | -0.0 | - | 139.9 | -1.8 | -2.4 | -4.2 | -5.6 | -1.4 | -988.9 | -715.4 | -532.7 | - |
ROE % |
1531.12 | 8333.79 | 1170.74 | -112.24 | -803.50 | 171.19 | -92.25 | -63.46 | -70.29 | -56.80 | -42.77 | -46.39 | -21.03 | -208.24 |
ROA % |
-268.39 | -346.86 | -509.81 | -86.17 | -303.53 | -12253.39 | -23.01 | -22.51 | -27.11 | -28.76 | -17.89 | -25.96 | -15.21 | -21.08 |
ROCE % |
2439.47 | 8316.05 | 1168.67 | -112.70 | -741.23 | 165.47 | -32.02 | -34.89 | -12.26 | -20.73 | -22.74 | -31.65 | -16.27 | -93.82 |
Current Ratio |
0.9 | 1.0 | 0.7 | 4.3 | 1.6 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.3 | 1.1 | 0.2 |
DSO |
- | - | - | - | - | - | 3.9 | 4.2 | 4.6 | 9.6 | 3.4 | 10.1 | 18173.6 | 343.7 |
DIO |
- | - | - | - | - | - | 4.4 | 4.5 | 5.5 | 8.4 | 366.9 | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | 3843.1 | - | - | - |
Operating Cycle |
- | - | - | - | - | - | 8.2 | 8.7 | 10.1 | 18.0 | 370.3 | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | 8.2 | 8.7 | 10.1 | 18.0 | -3472.8 | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Sonnet BioTherapeutics Holdings
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.7 | 0.08 | -0.31 | - | -2.95 | -7.55 | -17.62 | -0.37 | -1.82 | -1.91 | -1.44 | -0.93 | -0.27 | -0.32 | -0.34 | -2.23 | -1.05 | -0.34 | -0.44 | -0.39 | -0.26 | -13.28 | - | -0.34 | -0.23 | -0.83 | - | -0.7 | -0.81 | -0.79 | - | -0.41 | -2.35 | -0.07 | - | -0.31 | -0.24 | -0.27 | - | -0.52 | -0.07 | -0.24 | - | -0.38 | -0.19 | -0.2 | - | -0.2 | -0.56 | -0.28 | - | -0.4 | -0.18 | 0.11 |
EBITDA per Share |
- | - | -0.34 | - | - | - | -17.8 | -4.02 | -1.82 | -1.91 | -1.44 | -0.93 | -0.28 | -0.32 | -0.34 | -2.23 | -1.04 | -0.32 | -0.44 | -0.37 | -0.16 | -8.63 | - | -0.04 | 0.03 | -0.58 | - | -0.33 | -0.2 | -0.18 | - | 0.03 | 0.03 | -0.02 | - | -0.05 | -0.11 | -0.23 | - | -0.01 | -0.02 | -0.26 | - | -0.16 | -0.12 | -0.18 | - | -0.13 | -0.31 | -0.17 | - | -0.22 | -0.18 | 0.11 |
ROE % |
-282.81 | -264.37 | -381.89 | -64.33 | 813.53 | -101.76 | -92.40 | -286.91 | -1245.78 | -661.87 | -864.30 | -590.17 | -272.87 | 410.26 | 945.17 | 811.78 | 662.26 | 402.42 | 173.99 | 67.16 | -36.27 | -22.96 | -65.78 | -77.83 | -77.15 | -85.10 | -50.29 | -57.49 | -48.71 | -70.74 | -58.76 | -79.52 | -93.08 | -69.21 | -47.53 | -51.21 | -34.13 | -21.33 | -16.85 | -32.32 | -44.10 | -46.84 | -28.32 | -41.70 | -39.62 | -48.59 | -41.37 | -143.43 | -232.10 | -263.36 | -102.11 | -102.06 | -46.52 | 46.46 |
ROA % |
-115.51 | -94.37 | -143.13 | -194.03 | -576.30 | -642.14 | -654.12 | -571.90 | -251.82 | -231.87 | -198.14 | -362.03 | -373.35 | -361.64 | -414.33 | -228.38 | -6365.70 | -6295.30 | -6222.37 | -6215.52 | -8.84 | -8.28 | -16.41 | -21.09 | -22.61 | -26.50 | -17.84 | -20.54 | -17.57 | -26.21 | -22.05 | -32.75 | -40.75 | -34.09 | -24.50 | -26.04 | -16.88 | -10.00 | -7.13 | -14.22 | -19.77 | -21.74 | -14.28 | -23.95 | -26.54 | -34.06 | -29.91 | -40.24 | -40.90 | -34.58 | -10.34 | -10.33 | -4.71 | 4.70 |
ROCE % |
-425.69 | -405.44 | -384.30 | -61.38 | 816.71 | -98.22 | -88.92 | -285.50 | -1245.09 | -671.52 | -873.83 | -600.15 | 154.63 | 1083.59 | 1617.88 | 1485.01 | 960.50 | 464.09 | 275.31 | 163.37 | 5.56 | 23.25 | -46.73 | -59.79 | -63.82 | -68.27 | -32.40 | -36.52 | -27.58 | -21.60 | -15.45 | -20.43 | -21.29 | -24.46 | -21.02 | -24.57 | -23.14 | -19.27 | -17.49 | -28.09 | -35.15 | -37.84 | -23.62 | -37.39 | -40.56 | -45.89 | -34.43 | -93.34 | -138.48 | -174.26 | -62.03 | -58.91 | -47.23 | 44.12 |
Current Ratio |
1.8 | 2.1 | 1.9 | 1.0 | 1.5 | 1.7 | 0.6 | 0.7 | 1.1 | 2.3 | 4.8 | 4.3 | 1.2 | 4.3 | 0.6 | 1.6 | 1.6 | 1.6 | 0.9 | 0.0 | 1.2 | 1.2 | 1.4 | 1.4 | 1.4 | 1.4 | 1.6 | 1.6 | 1.6 | 1.6 | 1.7 | 1.7 | 1.7 | 1.7 | 2.1 | 2.1 | 2.1 | 2.1 | 1.7 | 1.7 | 1.7 | 1.7 | 2.3 | 2.3 | 2.3 | 2.3 | 3.6 | 3.6 | 3.6 | 3.6 | 1.1 | 1.1 | 1.1 | 1.1 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.6 | - | 3.5 | 4.4 | 4.1 | - | 3.4 | 3.4 | 3.9 | - | 4.0 | 4.0 | 4.6 | - | 4.4 | 4.5 | 6.3 | - | 8.5 | 9.3 | 6.3 | - | 3.1 | 4.4 | 4.6 | - | 12.9 | 12.4 | 10.6 | - | 8.5 | 8.5 | 8.7 | - | -1694.8 | 289.0 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.6 | - | 3.5 | 4.4 | 4.1 | - | 3.4 | 3.4 | 3.9 | - | 4.0 | 4.0 | 4.6 | - | 4.4 | 4.5 | 6.3 | - | 8.5 | 9.3 | 6.3 | - | 3.1 | 4.4 | 4.6 | - | 12.9 | 12.4 | 10.6 | - | 8.5 | 8.5 | 8.7 | - | -1694.8 | 289.0 | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.6 | - | 3.5 | 4.4 | 4.1 | - | 3.4 | 3.4 | 3.9 | - | 4.0 | 4.0 | 4.6 | - | 4.4 | 4.5 | 6.3 | - | 8.5 | 9.3 | 6.3 | - | 3.1 | 4.4 | 4.6 | - | 12.9 | 12.4 | 10.6 | - | 8.5 | 8.5 | 8.7 | - | -1694.8 | 289.0 | - |
All numbers in USD currency